UNICA IRIS Institutional Research Information System

FIRINU, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 141.250
NA - Nord America 5.686
AS - Asia 841
AF - Africa 24
SA - Sud America 24
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 147.840
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 139.574
US - Stati Uniti d'America 5.633
SE - Svezia 523
CN - Cina 494
UA - Ucraina 415
DE - Germania 190
FI - Finlandia 167
GB - Regno Unito 150
VN - Vietnam 102
FR - Francia 75
SG - Singapore 60
CA - Canada 46
TR - Turchia 36
HK - Hong Kong 31
NL - Olanda 28
IN - India 23
BE - Belgio 21
IR - Iran 17
ES - Italia 15
IE - Irlanda 15
RU - Federazione Russa 15
ID - Indonesia 14
KR - Corea 14
CO - Colombia 10
AU - Australia 9
IL - Israele 9
PT - Portogallo 9
JP - Giappone 8
TW - Taiwan 7
ZA - Sudafrica 7
CL - Cile 5
DK - Danimarca 5
MK - Macedonia 5
RO - Romania 5
BR - Brasile 4
CH - Svizzera 4
EU - Europa 4
IQ - Iraq 4
LT - Lituania 4
MX - Messico 4
MY - Malesia 4
NG - Nigeria 4
AT - Austria 3
HR - Croazia 3
HU - Ungheria 3
KE - Kenya 3
NO - Norvegia 3
PH - Filippine 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
KW - Kuwait 2
LU - Lussemburgo 2
LY - Libia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PL - Polonia 2
PR - Porto Rico 2
RS - Serbia 2
SD - Sudan 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
BD - Bangladesh 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
PK - Pakistan 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 147.840
Salva come PNG Salva come JPEG
Città #
Cagliari 138.808
Fairfield 799
Woodbridge 559
Chandler 534
Houston 454
Ashburn 444
Nyköping 405
Wilmington 323
Seattle 275
Cambridge 251
Ann Arbor 246
Jacksonville 204
Boardman 138
Dearborn 110
Helsinki 110
Shanghai 105
Dong Ket 102
Boston 90
Beijing 85
Nanjing 81
New York 80
San Diego 69
Redwood City 62
Rome 62
Milan 47
Nanchang 31
Toronto 31
London 29
Guangzhou 28
Verona 27
Washington 27
Changsha 26
Hong Kong 25
Shenyang 24
Kocaeli 21
Los Angeles 19
Mountain View 19
Sassari 19
Norwalk 18
Redmond 17
Brussels 16
Jiaxing 16
Monserrato 16
Hebei 14
Tianjin 14
Paris 13
Bari 11
Jinan 11
Orange 11
Sestu 11
Chicago 10
Jakarta 10
Phoenix 10
Rheinfelden 10
Zhengzhou 10
Quartu Sant'Elena 9
Auburn Hills 8
Gyeongsan-si 8
Leawood 8
Ningbo 8
Palermo 8
Romainville 8
San Mateo 8
Turin 8
Amsterdam 7
Augusta 7
Bogazici 7
Borås 7
Dublin 7
Hangzhou 6
Naples 6
Pune 6
Quartu Sant'elena 6
Andover 5
Columbus 5
Florence 5
La Spezia 5
Ploaghe 5
Salerno 5
Tortolì 5
Truccazzano 5
Bogotá 4
Brooklyn 4
Chennai 4
Chiswick 4
Dallas 4
Edinburgh 4
Escalaplano 4
Grassano 4
Hefei 4
Hounslow 4
Istanbul 4
Kunming 4
Lissone 4
Luras 4
Monmouth Junction 4
Olbia 4
Perugia 4
Pretoria 4
Rohnert Park 4
Totale 145.235
Salva come PNG Salva come JPEG
Nome #
The salivary proteome profile in patients affected by SAPHO syndrome characterized by a top-down RP-HPLC-ESI-MS platform 3.592
Overexpression of the cytokine BAFF and autoimmunity risk 3.487
Systemic lupus erythematosus occurring in a patient with Niemann-Pick type B disease. 3.071
TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome 3.002
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 2.832
The Salivary Proteome Profile in Patients Affected by SAPHO Syndrome characterized by a top-down RP-HPLC-ESI-MS platform 2.823
Zinc status and autoimmunity: A systematic review and meta-analysis 2.602
Alteration of the salivary secretory proteome profile in adults affected by antibody deficiency diseases 2.542
Characterization of patients with angioedema without wheals: The importance of F12 gene screening 2.503
Fungal allergy in asthma 2.489
SAPHO Syndrome: Current developments and approaches to clinical treatment 2.418
Biological treatments for SAPHO syndrome: an update 2.268
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.117
Alteration of the Salivary Secretory Proteome Profile in Adults Affected by Immune Deficiency Diseases 2.063
Evaluation of olfactory function as a potential biomarker in patients with Mastocytosis 2.022
Oxidative stress markers in patients with hereditary angioedema 2.007
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 1.923
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 1.912
Increased peripheral T(H)17 Cells in SAPHO syndrome: a novel target for treatment? 1.910
RP-HPLC-ESI-IT Mass Spectrometry Reveals Significant Variations of the Human Salivary Protein Profile Associated with Predominantly Antibody Deficiencies 1.910
Biologics for ANCA-associated vasculitis 1.881
An uncommon cause of refractory pleural effusion in an elderly patient 1.871
Periodic fever syndromes and autoinflammatory diseases: a case series from an Italian centre 1.841
COVID-19 in the mediterranean area: Epidemiology and main disease characteristics - A narrative review 1.805
Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report 1.726
Genetic variants regulating immune cell levels in health and disease 1.720
Mutation of angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema 1.645
The role of genetics in the current diagnostic workup of idiopathic non-histaminergic angioedema 1.592
Asthma and psychiatric disorders 1.580
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 1.561
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.539
Proteomic Analysis of the Acid-Insoluble Fraction of Whole Saliva from Patients Affected by Different Forms of Non-histaminergic Angioedema 1.526
Genetic factors associated with levels of immune cell types 1.517
Vaping effects on asthma: results from a web survey and clinical investigation 1.485
Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole 1.444
Exercise and asthma: an overview 1.440
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.423
Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency: a case report 1.421
Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis 1.398
Relevance of essential trace elements in nutrition and drinking water for human health and autoimmune disease risk 1.391
Influenza burden, prevention and treatment in asthma - a scoping review by the EAACI Influenza in Asthma Task Force 1.383
The climate in the European Union and the enlarged European Region is a determinant of the COVID-19 case fatality ratio 1.366
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma 1.318
Hyperosinophilia and recurrent angioedema in a patient with giant cell arteritis: a diagnostic "glitch" in a case of Gleich's syndrome 1.314
Baricitinib exposure during pregnancy in rheumatoid arthritis 1.277
Is hereditary angioedema related to an increased risk of atherosclerosis? 1.272
Biologics for SAPHO syndrome: a single centre experience 1.269
A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout 1.269
Celiac disease: peripheral blood cell-mediated response to antigen-specific stimulation 1.266
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype 1.253
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 1.224
Exercise training, lymphocyte subsets and their cytokines production: experience of an Italian professional football team and their impact on allergy 1.220
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma 1.145
An uncommon association of antiphospholipid syndrome, selective IgA deficiency and resistant-to-treatment relapsing polychondritis: efficacy of Infliximab 1.111
Melkersson-Rosenthal Syndrome: A case report 1.109
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 1.099
Urticaria and angioedema as possible misleading skin symptoms in families with hereditary angioedema 1.090
Management of Intermittent and Persistent Asthma in Adolescent and High School Athletes 1.064
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor 1.032
Angioedema without wheals: a retrospective analysis of a single center cohort 1.017
The COVID-19 incidence in Italian regions correlates with low temperature, mobility and PM10 pollution but lethality only with low temperature 1.017
EAACI Biologicals Guidelines—Recommendations for severe asthma 1.007
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 1.007
Idiopathic pyoderma gangrenosum: Successful resolution with Infliximab therapy and proinflammatory cytokines assessment 1.004
Raynaud's phenomenon and scleroderma associated with silicone gel breast implants: An example of Asia syndrome 982
Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency 976
Clinical pitfalls of leishmaniasis and Whipple’s disease hidden behind systemic lupus erythematosus: A case series 973
Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie = Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic 959
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma 954
Adult antibody deficiency syndrome and Henoch-Schoenlein Purpura: a report of two cases 920
Oxidative stress in hereditary angioedema caused by C1 inhibitor deficiency: An interesting finding that deserves further studies 920
Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: A case report 892
A promising new treatment for SAPHO syndrome that deserves further studies 889
Olfactory Function Is Impaired in Patients with Mastocytosis 853
A Novel Mutation in the SERPING1 Gene in Patients with Hereditary Angioedema and a Coexistent Complement Deficiency 835
Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery 820
COVID-19 Case Fatality Ratio of Latino America Countries with Temperate Climate Partially Follows European and Oceania Trends According to Seasonal Change 764
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 760
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 728
null 685
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic. Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H 685
null 673
Exercise-Induced Asthma: An update 660
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 657
null 648
null 640
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 619
Long-term complication of inadequate substitution therapy in the course of Common Variable Immunodeficiency: Systemic AA amyloidosis 617
null 596
Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency 589
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor 588
Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency 546
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 542
null 522
Familial CMC with possible autosomal recessive inheritance: a case report 516
La Sindrome Di Churg-Strauss: Presentazione Di Casi Clinici 511
Efficacy of FIRAZYR (Icatibant) in Treating Acute Abdominal Attacks 508
Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study 500
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study 487
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 484
Totale 134.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 186.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.652
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.243 0 0 0 0 0 0 0 0 0 404 459 380
2019/202024.709 1.112 699 119 377 9.052 6.511 3.543 787 490 573 501 945
2020/202144.906 1.061 1.527 1.511 11.946 8.988 5.090 3.203 3.109 1.519 2.594 2.618 1.740
2021/202212.565 1.277 721 586 986 922 896 795 607 1.311 1.144 1.659 1.661
2022/202317.536 1.347 2.302 2.432 1.366 1.532 1.814 944 1.546 1.052 991 1.336 874
2023/202416.910 1.275 782 982 1.622 1.958 3.458 3.065 1.675 997 1.096 0 0
Totale 148.424